A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis

NCT01922843 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperparathyroidism, Secondary
Kidney Failure, Chronic

Interventions

DRUG: DP001 softgel capsules
DRUG: Placebo

Sponsor

Deltanoid Pharmaceuticals